• Explore /
  • Poster
  • / Anthracycline-induced cardiotoxicity in patients with early stage breast cancer: The Canadian cancer trials group (NCIC CTG) MA.21 experience.

Anthracycline-induced cardiotoxicity in patients with early stage breast cancer: The Canadian cancer trials group (NCIC CTG) MA.21 experience.

Abstract Poster

Authors

null

Susan Faye Dent

Ottawa Hospital Cancer Centre, Ottawa, ON, Canada

Susan Faye Dent , Olexiy Aseyev , Mark Norman Levine , Kathleen I. Pritchard , Wendy R. Parulekar , Bingshu E. Chen , Patti O'Brien , Margot J. Burnell , Lois E. Shepherd

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Cytotoxic Chemotherapy

Clinical Trial Registration Number

NCT00014222

Citation

J Clin Oncol 34, 2016 (suppl; abstr 1016)

DOI

10.1200/JCO.2016.34.15_suppl.1016

Abstract #

1016

Poster Bd #

121

Abstract Disclosures

Similar Posters

First Author: Katherine Lovat

First Author: Lichen Tang

First Author: Laura Spring

First Author: Rosana Gnanajothy